Physician profile
Aimee Eichen
NPI 1699851428
$1,776.07
in general payments reported to CMS, 2019-2025
10 companies · $311 in 2025
The $311 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $425 · 2020: $145 · 2021: $181 · 2022: $202 · 2023: $387 · 2024: $125 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $501.53 | 2019-2023 | Clareon |
| Bausch & Lomb Americas INC. | $275.00 | 2024-2025 | Envista Mx60 Iol, Miebo, Xiidra |
| Glaukos Corporation | $232.28 | 2019-2025 | Idosetr |
| Genentech USA, INC. | $125.00 | 2023 | Vabysmo |
| Omeros Corporation | $124.90 | 2019 | |
| Sun Pharmaceutical Industries INC. | $122.11 | 2023 | Cequa |
| Kala Pharmaceuticals, INC. | $119.32 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $109.60 | 2021 | |
| Abbvie INC. | $95.04 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $71.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Eichen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.